Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed. Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.

CAS：679-84-5
中文别名：
英文别名：
分子式：C3H3BrF4
分子量：194.954
精确质量：193.935
Psa：0.0
Logp：2.2817

UNII：3DC4A5894W